A cytohistological study of Ki-67 expression in ovarian tumors

Indian Journal of Pathology and Microbiology

Volumn 54, Issue 1, 2011, Pages 21-24

  Choudhury, Monisha ^a   Goyal, Seema ^a   Pujani, Mukta ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Ki 67; ovary; tumors

Indexed keywords

KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR IMPRINTING; OVARY CARCINOMA; OVARY TUMOR; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEX CORD TUMOR; SMALL CELL CARCINOMA;

ADULT; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICROSCOPY; OVARIAN NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 79952943838     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.77318     Document Type: Article

References (14)

1. Souka S, Kamel M, Rocca M, El-Assi M, Hebeishy N, Sheir SH. The combined use of cytological and frozen section in the intraoperative diagnosis of ovarian tumors. Int J Gynecol Obstet 1990;31:43-6. (Pubitemid 20023650)
2. Wong WS, Tattersall MH. Immunohistochemical determination of tumor growth fraction in human ovarian carcinoma. Br J Obstet Gynaecol 1989;96:720-4. (Pubitemid 19172194)
3. Gupta MC, Mahajan BK. Epidemiology of non communicable diseases. In: Gupta MC, Mahajan BK, editors. Textbook of Preventive and Social Medicine. 3rd ed. New Delhi: Jaypee Brothers; 2003. p. 306-28.
4. Crum CP. The female genital tract. In: Kumar V, Abaas AK, Fausto N, editors. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia: WB Saunders Company; 2004. p. 1059-118.
5. Scucchi LF, Di Stefano D, Cosentino L, Vecchione A. Value of cytology as adjunctive intraoperative diagnostic method: An audit of 2250 consecutive cases. Acta Cytol 1997;41:1489-96. (Pubitemid 27391620)
6. Nagai Y, Tanaka N, Horiuchi F, Ohki S, Seki K, Sekiya S. Diagnostic accuracy of intraoperative imprint cytology in ovarian epithelial tumors. Int J Gynaecol Obstet 2001;72:159-64. (Pubitemid 32141084)
7. Brown DC, Gatter KC. Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 1990;17:489-503.
8. Garzetti GG, Ciavattini A, Goteri G, De Nictolis M, Stramazzotti D, Lucarini G, et al. Ki-67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: Index of proliferative activity with prognostic significance. Gynecol Oncol 1995;56:169-74.
9. Harlozinska A, Bar JK, Sedlaczek P, Gerber J. Expression of p53 protein and Ki-67 reactivity in ovarian neoplasms: Correlation with histopathology. Am J Clin Pathol 1996;105:334-40. (Pubitemid 26077375)
10. Viale G, Maisonneuve P, Bonoldi E, Di Bacco A, Bevilacqua P, Panizzoni GA, et al. The combined evaluation of p53 accumulation and Ki-67 (MIB 1) labeling index provides independent information on overall survival of ovarian carcinoma patients. Ann Oncol 1997;8:469-76. (Pubitemid 27310692)
11. Jordan PA, Kerns BJ, Pence JC, Kohler MF, Bast RC Jr, Kinney RB, et al. Determination of proliferation index in advanced ovarian cancer using quantitative image analysis. Am J Clin Pathol 1993;99:736-40. (Pubitemid 23181825)
12. Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, et al. Ovarian carcinoma subtypes are different diseases: Implications for biomarker studies. PLoS Med 2008;5:e232.
13. Khouja MH, Baekelandt M, Nesland JM, Holm R. The Clinical Importance of Ki-67, p16, p14, and p57 Expression in patients with advanced ovarian carcinoma. Int J Gynecol Pathol 2007;26:418-25. (Pubitemid 47476327)
14. Min KW, Park MH. The expression of c-erbB-2, EGFR, p53 and Ki-67 in ovarian borderline tumors and carcinomas of the ovary. Korean J Pathol 2007;41:296-306.